Hemodialysis significantly decreased the mean plasma concentration of the ANF C-terminus from 123 to 80 fmol/ml (p<0.001) in patients with end-stage renal disease.
Observational (n=13)
Does hemodialysis alter the plasma concentrations of different fragments of the atrial natriuretic factor prohormone in patients with end-stage renal disease?
Hemodialysis differentially affects the clearance of ANF prohormone fragments, decreasing the C-terminus while increasing the N-terminus and midportion fragments due to differences in dialyzer membrane permeability.
Absolute Event Rate: 80% vs 123%
p-value: p=<0.001
Plasma concentrations of the immunoreactive N-terminus, C-terminus and 4,000-dalton midportion of the N-terminus of the atrial natriuretic factor (ANF) prohormone were measured before and after hemodialysis in 13 patients with end-stage renal disease. There was a significant (p less than 0.001) fall in the mean plasma concentration of the C-terminus (i.e. ANF, amino acids 99-126 of the prohormone) from 123 +/- 25 to 80 +/- 22 fmol/ml (mean +/- SEM) with dialysis. The whole N-terminus, on the other hand, increased from 9,336 +/- 2,011 to 11,021 +/- 2,134 fmol/ml after dialysis (p less than 0.002). Pro ANF 31-67 (i.e. amino acids 31-67 of the prohormone) increased postdialysis from 27,775 +/- 4,300 to 31,040 +/- 4,840 fmol/ml (p less than 0.003). Only 1.5% of pro ANF 1-98 and pro ANF 31-67 were cleared by the dialyzer membrane while 15% of ANF crossed the membrane. Thus, with hemodialysis the C-terminus decreases while the N-terminus and pro ANF 31-67 from the midportion of the N-terminus of the ANF prohormone increase in plasma which is partially explained by their respective abilities to cross the dialyzer membrane.
Winters et al. (Thu,) conducted a observational in End-stage renal disease (n=13). Hemodialysis vs. Pre-hemodialysis baseline was evaluated on Plasma concentration of the C-terminus of the ANF prohormone (p=<0.001). Hemodialysis significantly decreased the mean plasma concentration of the ANF C-terminus from 123 to 80 fmol/ml (p<0.001) in patients with end-stage renal disease.